Simplified Monitoring for Hepatitis C Virus Treatment with Glecaprevir plus Pibrentasvir, a Randomised Non-Inferiority Trial
Ana Gabriela Pires dos Santos
(1)
,
Ed Gane
(2)
,
Gregory J. Dore
(3, 4)
,
Jordan J. Feld
(5)
,
Alex Thompson
(3, 6)
,
Marianne Martinello
(4)
,
Andrew J. Muir
(7)
,
Kosh Agarwal
(8)
,
Beat Müllhaupt
(9)
,
Heiner Wedemeyer
(10)
,
Karine Lacombe
(11)
,
Gail V. Matthews
(4, 3)
,
Michael Schultz
,
Marina Klein
(12)
,
Christophe Hezode
(13)
,
Gerard Estivill Mercade
(4)
,
Danny Kho
(4)
,
Kathy Petoumenos
(4)
,
Philippa Marks
(4)
,
Fernando Tatsch
(1)
1
Abbvie Inc. [North Chicago]
2 Auckland City Hospital
3 St. Vincent's Hospital, Sydney
4 UNSW - The Kirby Institute for Infection and Immunity in Society
5 TGHRI - Toronto General Hospital Research Institute [Canada]
6 University of Melbourne
7 Duke University [Durham]
8 KCH - King's College Hospital
9 University hospital of Zurich [Zurich]
10 Uniklinik Essen - Universitätsklinikum Essen [Universität Duisburg-Essen]
11 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
12 MUHC - McGill University Health Center [Montreal]
13 IMRB - Institut Mondor de Recherche Biomédicale
2 Auckland City Hospital
3 St. Vincent's Hospital, Sydney
4 UNSW - The Kirby Institute for Infection and Immunity in Society
5 TGHRI - Toronto General Hospital Research Institute [Canada]
6 University of Melbourne
7 Duke University [Durham]
8 KCH - King's College Hospital
9 University hospital of Zurich [Zurich]
10 Uniklinik Essen - Universitätsklinikum Essen [Universität Duisburg-Essen]
11 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
12 MUHC - McGill University Health Center [Montreal]
13 IMRB - Institut Mondor de Recherche Biomédicale